BioSpace News Archive

Discovery Park & Pfizer UK hosting sell-out UK MMIP Annual Conference 2019 today Also announced

The sell-out UK Manufacturing Medicines Industry Partnership (MMIP) Annual Conference is taking place at Discovery Park today.

June 20, 2019
·
3 min read
Business

DIXI Group partners with Aleva Neurotherapeutics to develop new generation of deep brain surgical electrodes for epilepsy treatment

DIXI Holding Le Locle SA and Aleva Neurotherapeutics SA have co-founded Adept Neuro SA, a Joint Venture dedicated to developing a new generation of Stereo-Electro-Encephalo-Graphie (SEEG) electrodes which will facilitate localization and thermocoagulation of epileptogenic zones.

June 20, 2019
·
2 min read
Business

Bentec Medical Appoints CEO for Next Phase of Growth

Bentec Medical, a market leader in the design and manufacture of silicone-based components for both major OEM Medical Device manufacturers as well as proprietary products serving surgical applications, announces the appointment of industry veteran JG Singh as the Company’s CEO.

June 20, 2019
·
1 min read
Policy

Study finds dramatic 74% increase in youth vaping in Canada

Canadian Cancer Society calls for immediate action by federal and provincial governments

June 20, 2019
·
3 min read
CSL Behring to showcase clinical advances and insights in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with Hizentra ® [human normal immunoglobulin, 20%, subcutaneous], at the 2019 Peripheral Nerve Society Annual Meeting

Global biotherapeutics leader CSL Behring announced that it will support the presentation of eight scientific posters at the 2019 annual meeting of the Peripheral Nerve Society (PNS), to be held 22-26 June, in Genoa, Italy.

June 20, 2019
·
5 min read
Business

Spectrum Pharmaceuticals Appoints Elizabeth Czerepak to its Board of Directors

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, announced the appointment of Elizabeth Czerepak to the Board of Directors.

June 20, 2019
·
3 min read
Deals

Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform

Tangen Biosciences, Inc., a molecular diagnostic company located in Branford, Connecticut, announced that it has closed a $9 million Series A equity round led by Connecticut Innovations, with participation of current and new stockholders, including VC23, Axiom, and Leading Edge Ventures.

June 20, 2019
·
3 min read
Drug Development

Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly

Camurus announced the acceptance by the US Food and Drug Administration of an Investigational New Drug application to initiate a Phase 3 study with CAM2029 once-monthly octreotide subcutaneous depot for treatment of acromegaly.

June 20, 2019
·
5 min read
Deals

Velan Calls on Progenics Pharmaceuticals’ Board to Back Up Recent Claims

Actual Stockholders, the True Owners of the Company, Deserve Answers and Clarity

June 20, 2019
·
7 min read
Business

Reminder: Centene Corporation’s 2019 Second Quarter Financial Results Conference Call

Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2019 second quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, July 23, 2019, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results

June 20, 2019
·
2 min read